top of page

Lifetime Health Optimization

Quant Biomarker is a Swiss life science, technology company. It focuses on Longevity Medicine using AI to develop personal biomarker panels. We deliver predictive biomarker-based platform for early detection of chronic diseases & new therapeutic targets for regenerative medicines

Company Goals

In a world where people stay healthy while aging, Quant Biomarkers' primary mission is to advance biomarker technologies, predict risks for the onset of chronic diseases to identify targets for personalized medical interventions

We target biology of aging as our foundation for disease prevention

QuantBio combines longitudinal clinical, health records & research data to evaluate multiple dimensions of aging. We complement this data with in-vitro, in-vivo models, proprietary assays  and Artificial Intelligence, to  deliver tangible guidance for decisions  that improve the quality of an individual's lifespan


Who we are

Quant Biomarkers is a data-driven biotechnology company that specialises in quantitative assessment of biomarkers of human longevity and in development of personalised biomarker panels as early targets for interventions in aging diseases


A world where people stay healthy while aging



Deveoping predictive biomarker-based platform for early detection of chronic diseases & new therapeutic  targets for regenerative medicines

Partnering with health care providers to bring early diagnostics to standard of care


We work with high-quality longitudinal human data and medical records that enable us to correlate our biological measurements with health outcomes. We use proprietary  invitro, in vivo models to determine which pathways are most strongly associated with diseases onset and identify critical intervention targets for healthy longevity


We develop tools that guide and empower medical decision-making, by all the stakeholders in the patient ecosystem

Untitled design.jpg

Our company strategic imperative:

Quant Biomarker’s focus is to drive for sustainable, preventive, and scalable digital health solutions for Healthy Lifespan


Our strategic direction is in developing personalised biomarker panels for aging related chronic diseases and selection of endpoints for interventions and multitreatment modalities


Our Deliverables

Proprietary products:

  • AI-based Algorithms for disease risk predictions and early interventions

  • Personalized medical intervention protocols

  • Tissue-specific Biomarker Panels for diagnostic use

  • New Biomarker IP for therapeutics

  • Digital Twin consumer application for Real-Time Data exchange & timely Interventions


Screenshot 2022-08-26 at 3.59.34 PM.png
Screenshot 2022-08-26 at 3.59.40 PM.png
Praxis (1).png
Untitled design (1).png
bottom of page